Cite
Antibody Light-Chain-Restricted Recognition of the Site of Immune Pressure in the RV144 HIV-1 Vaccine Trial Is Phylogenetically Conserved.
MLA
Wiehe, Kevin, et al. “Antibody Light-Chain-Restricted Recognition of the Site of Immune Pressure in the RV144 HIV-1 Vaccine Trial Is Phylogenetically Conserved.” Immunity (10747613), vol. 41, no. 6, Dec. 2014, pp. 909–18. EBSCOhost, https://doi.org/10.1016/j.immuni.2014.11.014.
APA
Wiehe, K., Easterhoff, D., Luo, K., Nicely, N. I., Bradley, T., Jaeger, F. H., Dennison, S. M., Zhang, R., Lloyd, K. E., Stolarchuk, C., Parks, R., Sutherland, L. L., Scearce, R. M., Morris, L., Kaewkungwal, J., Nitayaphan, S., Pitisuttithum, P., Rerks-Ngarm, S., Sinangil, F., & Phogat, S. (2014). Antibody Light-Chain-Restricted Recognition of the Site of Immune Pressure in the RV144 HIV-1 Vaccine Trial Is Phylogenetically Conserved. Immunity (10747613), 41(6), 909–918. https://doi.org/10.1016/j.immuni.2014.11.014
Chicago
Wiehe, Kevin, David Easterhoff, Kan Luo, Nathan I. Nicely, Todd Bradley, Frederick H. Jaeger, S. Moses Dennison, et al. 2014. “Antibody Light-Chain-Restricted Recognition of the Site of Immune Pressure in the RV144 HIV-1 Vaccine Trial Is Phylogenetically Conserved.” Immunity (10747613) 41 (6): 909–18. doi:10.1016/j.immuni.2014.11.014.